VALID TRIAL
Both CHIA and your personal trial have the following criteria:
╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                  │ CHIA Criteria                                      │   Score │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ Acute Coronary Syndrome group: 40 patients with    │ Acute Coronary Syndrome group: 40 patients with    │     100 │
│ type 1 myocardial infarction within 21 days prior  │ type 1 myocardial infarction within 21 days prior  │         │
│ to the imaging visit and invasive coronary         │ to the imaging visit and invasive coronary         │         │
│ angiography with angiographic evidence of at least │ angiography with angiographic evidence of at least │         │
│ a 50% stenosis in one or more coronary arteries.   │ a 50% stenosis in one or more coronary arteries.   │         │
│ Only patients undergoing PCI will be included in   │ Only patients undergoing PCI will be included in   │         │
│ the study                                          │ the study                                          │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Stable Ischemic Heart Disease group: 40 patients   │ Stable Ischemic Heart Disease group: 40 patients   │     100 │
│ who have undergone invasive coronary angiography   │ who have undergone invasive coronary angiography   │         │
│ within 21 days prior to the imaging visit, with    │ within 21 days prior to the imaging visit, with    │         │
│ history of typical angina prior to the angiogram,  │ history of typical angina prior to the angiogram,  │         │
│ but no prior myocardial infarction or coronary     │ but no prior myocardial infarction or coronary     │         │
│ revascularization                                  │ revascularization                                  │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ have no prior CAD associated event (no prior       │ have no prior CAD associated event (no prior       │     100 │
│ myocardial infarction, acute coronary syndrome,    │ myocardial infarction, acute coronary syndrome,    │         │
│ coronary angiogram, or PCI)                        │ coronary angiogram, or PCI)                        │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ History of severe allergy to Iodine contrast       │ History of severe allergy to Iodine contrast       │     100 │
│ agents                                             │ agents                                             │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Pregnancy                                          │ Pregnancy                                          │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Active atrial fibrillation                         │ Active atrial fibrillation                         │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Multiple premature ventricular or atrial           │ Multiple premature ventricular or atrial           │     100 │
│ contractions                                       │ contractions                                       │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Class III congestive heart failure                 │ Class III congestive heart failure                 │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Age \< 18 years                                    │ Age < 18 years                                     │      97 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Creatinine \> 1.5 mg/dL                            │ Creatinine > 1.5 mg/dL                             │      98 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Ejection fraction \<35%                            │ Ejection fraction <35%                             │      98 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ have CAC between 10 to \<1000, and                 │ have CAC between 10 to <1000, and                  │      99 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ match to patients in the ACS group by gender, age  │ match to patients in the ACS group by gender, age  │      99 │
│ by decile, and CAC category (using CAC categories  │ by decile, and CAC category (using CAC categories  │         │
│ of 10 to \<100, 100 to \<400, 400 to \<1000)       │ of 10 to <100, 100 to <400, 400 to <1000)          │         │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

Only your personal trial has the following criteria:
╒═══════════════════════════════════════════════════╤═══════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                 │ CHIA Criteria                                     │   Score │
╞═══════════════════════════════════════════════════╪═══════════════════════════════════════════════════╪═════════╡
│ Patients in the asymptomatic CAD group must       │ Creatinine > 1.5 mg/dL                            │      34 │
├───────────────────────────────────────────────────┼───────────────────────────────────────────────────┼─────────┤
│ Three groups of patients will be recruited for    │ Multiple premature ventricular or atrial          │      38 │
│ this study                                        │ contractions                                      │         │
├───────────────────────────────────────────────────┼───────────────────────────────────────────────────┼─────────┤
│ Must have minimum age of 18 Years                 │ Age < 18 years                                    │      47 │
├───────────────────────────────────────────────────┼───────────────────────────────────────────────────┼─────────┤
│ Asymptomatic CAD group: 40 patients who have      │ Stable Ischemic Heart Disease group: 40 patients  │      56 │
│ undergone Coronary Artery Calcium scanning within │ who have undergone invasive coronary angiography  │         │
│ 6 months prior to the imaging visit, matched to   │ within 21 days prior to the imaging visit, with   │         │
│ the ACS patients for age, gender, and CAC score   │ history of typical angina prior to the angiogram, │         │
│                                                   │ but no prior myocardial infarction or coronary    │         │
│                                                   │ revascularization                                 │         │
╘═══════════════════════════════════════════════════╧═══════════════════════════════════════════════════╧═════════╛

CHIA has no unique criteria

Levenshtein Ratio of Entire trial at once: 87
Average Levenshtein Ratio of individual lines: 86.23529411764706
OverAll Ratio: 86.61764705882354
